Related Experiment Video
Updated: Mar 31, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
12.5K
[Hepatocellular carcinoma and vitamin K2]
Toshihiko Mizuta1, Iwata Ozaki2
1Internal Medicine, Imari-Arita Kyoritsu Hospital, Japan.
Clinical Calcium
|October 28, 2015
Summary
Vitamin K2 (VK2) shows potential in suppressing hepatocellular carcinoma (HCC) growth, but its effectiveness is limited when used alone. Future research should explore combining VK2 with other anticancer agents for improved outcomes in HCC treatment.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Context:
- Hepatocellular carcinoma (HCC) presents a significant therapeutic challenge with poor prognoses despite advancements.
- Vitamin Ks (VKs) have demonstrated inhibitory effects on HCC cell proliferation.
Purpose:
- To evaluate the potential of Vitamin K2 (VK2) in managing hepatocellular carcinoma.
- To identify strategies for enhancing the anti-tumor efficacy of VK2.
Summary:
- Long-term administration of VK2 is clinically safe but lacks significant anti-tumor activity when used as a monotherapy.
- Future directions include exploring the co-administration of VK2 with established anticancer agents.
- Development of novel VK preparations with altered side-chain structures is also proposed.
Impact:
- This research may pave the way for more effective Vitamin K2-based therapies for HCC.
- Identifying synergistic combinations or improved formulations could enhance patient outcomes in HCC treatment.
More Related Videos
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:46Electron Transport Chain: Complex I and II
19.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
01:30Vitamins
3.0K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.0K
01:22Connective Tissue Cell Types
4.5K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.5K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
01:26Diseases of the Liver and Gallbladder
2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K